Please login to the form below

Not currently logged in
Email:
Password:

Celltrion Healthcare

This page shows the latest Celltrion Healthcare news and features for those working in and with pharma, biotech and healthcare.

Celltrion’s investigational mAb cuts COVID-19 recovery time

Celltrion’s investigational mAb cuts COVID-19 recovery time

South Korean-based Celltrion has posted positive data for its investigational COVID-19 targeting monoclonal antibody (mAb) from a phase 2/3 study. . ... especially in moderate patients aged 50 years and over,” said HoUng Kim head of medical and

Latest news

  • Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal

    Mundipharma has strengthened its partnership with biopharmaceutical group Celltrion Healthcare by securing rights to its trastuzumab biosimilar. ... Commenting on the partnership, Man Hoon Kim, president and CEO of Celltrion Healthcare, said: “We are

  • Standing out in a crowd Standing out in a crowd

    Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars. ... PME sat down recently to discuss pricing, market access and regulatory challenges with Ho-Ung Kim, division head of

  • Mundipharma to launch first MabThera biosimilar in EU Mundipharma to launch first MabThera biosimilar in EU

    approval. Developed by South Korean biosimilar specialist Celltrion Healthcare, Truxima is set to be launched in the UK, Germany, Italy, the Netherlands, Belgium, Ireland and Luxembourg by UK-based pharma network

  • Patients 'sceptical' about biosimilars, says EULAR Patients 'sceptical' about biosimilars, says EULAR

    A cost-effective treatment option like biosimilar infliximab will help to decrease the current and extensive burden on healthcare systems across Europe," commented Celltrion chief executive Stanley Hong. ... as $50bn in savings to healthcare systems

  • First mAb biosimilars set for European approval First mAb biosimilars set for European approval

    Celltrion and Hospira's versions of J&J's blockbuster Remicade recommended by CHMP. ... infliximab) filed by Celltrion Healthcare and Hospira.

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics